REFERENCES
- McLean, Jay: The thromboplastic action of cephalin. Am. J. Physiol., 41:250, 1916.
- Charles, A. F., and Scott, D. A.: Studies on heparin. IV. Observations on the chemistry of heparin. Biochem. J., 30: 1927, 1936.
- Chargaff, Erwin, Ziff, Morris, and Moore, D. H.: Studies on the chemistry of blood coagulation. XII. An electrophoretic study of the effect of anticoagulants on human plasma proteins, with remarks on the separation of the heparin complement. J. Biol. Chem., 139:383, 1941.
- de Takats, Geza: Heparin tolerance; a test of the clotting mechanism. Surg., Gynec. and Obst., 77:31. 1943.
- Murray, D. W. G., and Best, C. H.: Heparin and thrombosis; the present situation. J.A.M.A., 110:118; 1938.
- Priestley, J. T., and Barker, N. W.: Postoperative thrombosis and embolism; their treatment with heparin. Surg., Gynec. and Obst. 75:193, 1942.
- Crafoord, Clarence, and Jorpes, Erik: Heparin as a prophylactic against thrombosis. J.A.M.A., 116:2831, 1941.
- Loewe, Leo, Rosenblatt, Philip, and Hirsch, Edward: Venous thromboembolic disease. J.A.M.A., 130:386, 1946.
- Murray, G. D. W., and Best, C. H.: Use of heparin in thrombosis. Ann. Surg., 108:163, 1938.
- Murray, Gordon: Heparin in surgical treatment of blood vessels. Arch. Surg., 40:307, 1940.
- McClure, R. D., and Lam, C. R.: Experiences in heparin administration. J.A.M.A., 114:2085, 1940.
- Bauer, Gunnar: Thrombosis; early diagnosis and abortive treatment with heparin. Lancet, 1:447, 1946.
- Campbell, H. A., and Link, K. P.: Studies on the hemorrhagic sweet clover disease. IV. The isolation and crystallization of the hemorrhagic agent. J. Biol. Chem., 138:21, 1941.
- Stahmann, M. A., Huebner, C. F., and Link, K. P.: Studies on the hemorrhagic sweet clover disease. V. Identification and synthesis of the hemorrhagic agent. J. Biol. Chem., 138: 513. 1941
- Allen, E. V., Barker, N. W., and Waugh, J. M.: A preparation from spoiled sweet clover [3, 3′-methylene-bis-(4-hy- droxycoumarin)] which prolongs coagulation and prothrombin time of the blood: a clinical study. J.A.M.A., 120:100–9, 1942.
- Spooner, Maryloo, and Meyer, O. O.: The influence of dicumarol on platelet adhesiveness. J. Lab. and Clin. Med., 30:390, 1945.
- Wright, Helen P.: The adhesiveness of blood platelets in rabbits treated with dicoumarol. J. Path, and Exper. Bact., 57:382, 1945.
- Hum, Margaret, Barker, N. W., and Magath, T. B.: The determination of prothrombin time following the administration of dicumarol, 3, 3′-methylene-bis-(4-hydroxycoumarin), with special reference to thromboplastin. J. Lab. and Ciin. Med., 30:432, 1945.
- Barker, N. W., Cromer, H. E., Hurn, Margaret, and Waugh, J. M.: The use of dicumarol in the prevention of postoperative thrombosis and embolism with special reference to dosage and safe administration. Surgery, 17:207, 1945.
- Long, Mary, Hurn, Margaret, and Barker, N. W.: Effect of heparin on the prothrombin time. Proc. Staff Meet., Mayo Clin., 21:225, 1946.
- Bollman, J. L., and Preston, F. W.: The effects of experimental administration of dicoumarin; 3, 3′-methylene-bis-(4-hydroxycoumarin). J.A.M.A., 120:1021, 1942.
- Dale, D. U., and Jaques, L. B.: The prevention of experimental thrombosis by dicoumarin. Canad. M.A.J., 46:546, 1942.
- Richards, R. K., and Cortell, Ruth: Studies on the anticoagulant 3, 3′-methylene-bis-(4-hydroxycoumarin). Proc. Soc. Exper. Biol, and Med., 50:237, 1942.
- Barker, N. W.: Anticoagulant therapy in postoperative thrombophlebitis and pulmonary embolism. Minnesota Med. 29: 778, 1946.
- Barker, N. W., Nygaard, K. K., Walters, Waltman, and Priesdey, J. T.: A statistical study of postoperative venous thrombosis and pulmonary embolism. III. Time of occurrence during the postoperative period. Proc. Staff Meet., Mayo Clin., 16:17, 1941.
- Barker, N. W., Nygaard, K. K., Walters, Waltman, and Priestley, J. T.: A statistical study of postoperative venous thrombosis and pulmonary embolism. I. Incidence in various types of operations. Proc. Staff Meet., Mayo Clin., 15:769, 1940.
- Nay, R. M., and Barnes, A. R.: Incidence of embolic or thrombotic processes during the immediate convalescence from acute myocardial infarction. Am. Heart J., 30:65, 1945.
- Nichol, E. S., and Page, S. W., Jr.: Dicumarol therapy in acute coronary thrombosis; results in fifty attacks; with review of data on embolic complications and immediate mortality in myocardial infarction. J. Florida M. A., 32:365, 1946.
- Peters, H. R., Guyther, J. R., and Brambel, C. E.: Dicumarol in acute coronary thrombosis. J.A.M.A., 130:398, 1946.
- Wright, I. S.: Experiences with dicumarol (3, 3′-methylenebis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction. Am. Heart J. 32:20, 1946.
- Barker, N. W., Hines, E. A., Jr., and Kvale, W. F.: The treatment of acute arterial occlusion of the extremities with special reference to anticoagulant therapy. Minnesota Med., 29:250; 280, 1946.